Achieve Life Sciences Inc (ACHV) Wheel Strategy

Running a ACHV wheel strategy lets you generate consistent premium income on Achieve Life Sciences Inc while setting your own entry and exit prices on the underlying. Achieve Life Sciences Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own ACHV, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best ACHV wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on ACHV, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable ACHV wheel from a losing one.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the ACHV wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your ACHV wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.